Tel Aviv - Delayed Quote ILA

Purple Biotech Ltd (PPBT.TA)

4.3000
+0.2000
+(4.88%)
As of 2:24:16 PM GMT+3. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
10,803
10,803
22,271
22,603
17,934
Operating Income
-10,803
-10,803
-22,271
-22,603
-17,934
Net Non Operating Interest Income Expense
-212
-212
-1,707
536
241
Other Income Expense
3,736
3,736
4,001
307
-133
Pretax Income
-7,279
-7,279
-19,977
-21,760
-17,826
Tax Provision
--
--
--
--
0
Net Income Common Stockholders
-7,240
-7,240
-19,880
-21,668
-18,384
Diluted NI Available to Com Stockholders
-7,240
-7,240
-19,880
-21,668
-18,384
Basic EPS
-0.22
-0.22
-0.09
-0.12
-0.10
Diluted EPS
-0.25
-0.25
-0.09
-0.12
-0.10
Basic Average Shares
32,791.3200
32,791.3200
221,333
180,810.8000
175,680.3600
Diluted Average Shares
32,795.7400
32,795.7400
221,333
180,810.8000
175,680.3600
Total Operating Income as Reported
-11,005
-11,005
-22,271
-22,603
-17,934
Total Expenses
10,803
10,803
22,271
22,603
17,934
Net Income from Continuing & Discontinued Operation
-7,240
-7,240
-19,880
-21,668
-18,384
Normalized Income
-10,976
-10,976
-23,881
-21,975
-17,609
Interest Income
260
260
474
532
320
Interest Expense
41
41
56
67
79
Net Interest Income
-212
-212
-1,707
536
241
EBIT
-7,238
-7,238
-19,921
-21,693
-17,747
EBITDA
-7,052
-7,052
-19,724
-21,492
-17,516
Reconciled Depreciation
186
186
197
201
231
Net Income from Continuing Operation Net Minority Interest
-7,240
-7,240
-19,880
-21,668
-17,742
Total Unusual Items Excluding Goodwill
3,736
3,736
4,001
307
-133
Total Unusual Items
3,736
3,736
4,001
307
-133
Normalized EBITDA
-10,788
-10,788
-23,725
-21,799
-17,383
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 8/12/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LCTX.TA Lineage Cell Therapeutics, Inc.
171.90
+1.12%
 
EVGN.TA Evogene Ltd.
420.00
+2.07%
 
BLRX.TA BioLineRx Ltd.
1.9000
+5.56%
 
THAR Tharimmune, Inc.
1.4100
-1.40%
 
BLRX BioLineRx Ltd.
3.2500
+2.52%
 
SPRB Spruce Biosciences, Inc.
0.0655
-9.03%
 
IMTX Immatics N.V.
4.5200
+4.16%
 
EVGN Evogene Ltd.
1.2200
+6.09%
 
CGEN Compugen Ltd.
1.3700
+1.48%
 
LCTX Lineage Cell Therapeutics, Inc.
0.4799
+2.11%